⌘K
Loading ticker…
Jupiter Neurosciences, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Jupiter Neurosciences, Inc. Common Stock (JUNS) has a 3-month relative strength percentile of 17 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 31. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.4%, relative volume 6.25×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
17 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
JUNS is in a stage 4 downtrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.7% / -65.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
JUNS is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $48K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $48K |
| VTIVanguard Total Stock Market ETF | 0.00% | $12K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JUNS Jan avg: -69.31% median: -69.31% win: 0% σ: 29.78% n: 2 2024-12-04 → 2026-05-29 | JUNS Feb avg: -18.19% median: -18.19% win: 50% σ: 26.31% n: 2 2024-12-04 → 2026-05-29 | JUNS Mar avg: -17.66% median: -17.66% win: 0% σ: 16.07% n: 2 2024-12-04 → 2026-05-29 | JUNS Apr avg: 3.47% median: 3.47% win: 100% σ: 3.78% n: 2 2024-12-04 → 2026-05-29 | JUNS May avg: -6.39% median: -6.39% win: 50% σ: 36.91% n: 2 2024-12-04 → 2026-05-29 | JUNS Jun avg: 31.60% median: 31.60% win: 100% σ: 0.00% n: 1 2024-12-04 → 2026-05-29 (current) | JUNS Jul avg: 37.26% median: 37.26% win: 100% σ: 0.00% n: 1 2024-12-04 → 2026-05-29 | JUNS Aug avg: 5.00% median: 5.00% win: 100% σ: 0.00% n: 1 2024-12-04 → 2026-05-29 | JUNS Sep avg: 19.73% median: 19.73% win: 100% σ: 0.00% n: 1 2024-12-04 → 2026-05-29 | JUNS Oct avg: -18.75% median: -18.75% win: 0% σ: 0.00% n: 1 2024-12-04 → 2026-05-29 | JUNS Nov avg: -14.34% median: -14.34% win: 0% σ: 0.00% n: 1 2024-12-04 → 2026-05-29 | JUNS Dec avg: 39.08% median: 39.08% win: 50% σ: 78.94% n: 2 2024-12-04 → 2026-05-29 |